Cognitive dysfunction in AD extends beyond canonical Aβ and tau pathologies to encompass pathological microglial activation, characterized by a pronounced shift from a resting surveillant phenotype to a pro-inflammatory reactive state [24, 25] This phenotypic transition has been mechanistically linked to chronic exposure and aberrant sensing of AD associated pathogenic proteins. Here, MAPT is linked to Alzheimer disease.